Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Drug companies greet 2019 with U.S. price hikes

Drugmakers kicked off 2019 with price increases in the United States on more than 250 prescription drugs, including the world’s top-selling medicine Humira, although the pace of price hikes was slower than during 2018.

Read More »

Genentech Cutting More Jobs in Bay Area

South San Francisco-based Genentech filed with the State of California, indicating that the Roche company planned to cut 83 jobs.

Read More »

California insurance regulator sues AbbVie alleging Humira kickbacks

Insurance Commissioner Dave Jones filed a complaint on behalf of the State of California against AbbVie Inc., alleging the drugmaker gave illegal kickbacks to healthcare providers to prescribe the company’s blockbuster medicine Humira.

Read More »

VC Startup Westlake Village BioPartners Launches With Amgen Vets, $320 Million Fund

There is a new player in the southern California biotech industry as new venture firm Westlake Village BioPartners launched with a $320 million fund.

Read More »

Indivior subpoenaed by California on opioid addiction treatment

Britain’s Indivior was subpoenaed by the California Department of Insurance over its blockbuster opioid addiction treatment Suboxone Film, which is rapidly losing market share due to stiff competition from generic versions.

Read More »

Cancer warnings to be served up with coffee in California

Starbucks Corp. and other roasters and retailers must serve up a cancer warning with coffee sold in California, a Los Angeles judge ruled.

 

Read More »

California court says Novartis can be sued over generic drug injuries

California’s top court opened the door for consumers to sue Novartis AG and other makers of brand-name pharmaceutical products over injuries blamed on generic versions of the drugs manufactured by other companies.

Read More »

PhRMA sues to stop California drug price law

The trade group representing U.S. drugmakers filed a lawsuit to stop California from implementing a law aimed at reining in prescription drug prices.

Read More »

Johnson & Johnson wins California lawsuit claiming asbestos in talc caused cancer

A California jury ruled in favor of Johnson & Johnson in a lawsuit by a woman who said she developed the cancer mesothelioma after being exposed to asbestos in the company’s talc-based products including J&J’s Baby Powder.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

February 2019 Focus: Agenda 2019, Top 10 Pipelines To Watch, Value Of Pharmaceuticals, and more!

Subscribe

Ad Right Bottom